Expression of concern for "exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment".
作者信息
Cho C S
机构信息
Editor-in-Chief, Clinical Medicine Insights: Oncology.
出版信息
Clin Med Insights Oncol. 2013 May 20;7:83. doi: 10.4137/CMO.S11911. Print 2013.
Abstract
摘要
相似文献
1
Expression of concern for "exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment".对“脐带血来源的树突状细胞呈递人卵巢癌腹水来源外泌体用于免疫治疗的体外实验”的关注声明
Clin Med Insights Oncol. 2013 May 20;7:83. doi: 10.4137/CMO.S11911. Print 2013.
2
Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment.脐带血来源的树突状细胞呈递的人卵巢癌腹水来源外泌体用于免疫治疗的体外实验。
Clin Med Oncol. 2008;2:461-7. doi: 10.4137/cmo.s776. Epub 2008 Jun 11.
3
Umbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivo.负载BGC823肿瘤抗原的脐带血来源树突状细胞和树突状细胞来源的外泌体在体外和体内均可刺激有效的细胞毒性T淋巴细胞反应和抗肿瘤免疫。
Cent Eur J Immunol. 2014;39(2):142-51. doi: 10.5114/ceji.2014.43713. Epub 2014 Jun 27.
4
Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity.卵巢癌患者腹水中的外泌体：来源及其对抗肿瘤免疫的影响。
Oncol Rep. 2011 Mar;25(3):749-62. doi: 10.3892/or.2010.1119. Epub 2010 Dec 22.
5
Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial.用于临床试验的人卵巢癌腹水来源外泌体的制备。
Blood Cells Mol Dis. 2005 Sep-Oct;35(2):149-52. doi: 10.1016/j.bcmd.2005.06.008.
6
[Effects of ascites derived exosomes on the stemness and invasion ability of ovarian cancer stem-like cell].腹水来源的外泌体对卵巢癌干细胞样细胞干性及侵袭能力的影响
Zhonghua Fu Chan Ke Za Zhi. 2021 May 25;56(5):349-357. doi: 10.3760/cma.j.cn112141-20201129-00862.
7
The effects of umbilical cord-derived macrophage exosomes loaded with cisplatin on the growth and drug resistance of ovarian cancer cells.载顺铂的脐带源巨噬细胞外泌体对卵巢癌细胞生长和耐药性的影响。
Drug Dev Ind Pharm. 2020 Jul;46(7):1150-1162. doi: 10.1080/03639045.2020.1776320. Epub 2020 Jun 16.
8
[Isolation, identification and clinical significance of ascites-derived exosomes from patients with ovarian epithelial cancer].卵巢上皮癌患者腹水来源外泌体的分离、鉴定及临床意义
Zhonghua Fu Chan Ke Za Zhi. 2009 Apr;44(4):268-72.
9
Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7.人脐带间充质干细胞来源的外泌体 miR-17-5p 通过调控 SIRT7 改善卵巢早衰患者卵巢功能
Stem Cells. 2020 Sep;38(9):1137-1148. doi: 10.1002/stem.3204. Epub 2020 May 29.
10
LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer.脂多糖和白细胞介素-8激活的脐带血来源中性粒细胞可抑制卵巢癌进展。
J Cancer. 2020 May 18;11(15):4413-4420. doi: 10.7150/jca.41035. eCollection 2020.
引用本文的文献
1
Extracellular vesicle-coupled miRNA profiles in follicular fluid of cows with divergent post-calving metabolic status.牛产后代谢状态不同时卵泡液中细胞外囊泡结合 miRNA 谱的变化。
Sci Rep. 2019 Sep 6;9(1):12851. doi: 10.1038/s41598-019-49029-9.
Zotero 插件